Sunday, April 1, 2012

Chapter 10 Respiratory Function and Therapy


GENERAL OVERVIEW
RESPIRATORY FUNCTION
The major function of the pulmonary system (lungs and pulmonary circulation) is to deliver oxygen to cells and remove carbon dioxide (CO2) from the cells (gas exchange). The adequacy of oxygenation and ventilation is measured by partial pressure of arterial oxygen (PaO2) and partial pressure of arterial carbon dioxide (Paco2). The pulmonary system also functions as a blood reservoir for the left ventricle when it is needed to boost cardiac output; as a protector for the systemic circulation by filtering debris/particles; as a fluid regulator so water can be kept away from alveoli; and as a provider of metabolic functions such as surfactant production and endocrine functions.
Terminology
  • Alveolus—air sac where gas exchange takes place
  • Apex—top portion of the upper lobes of lungs
  • Base—bottom portion of lower lobes, located just above the diaphragm
  • Bronchoconstriction—constriction of smooth muscle surrounding bronchioles
  • Bronchus—large airways; lung divides into right and left bronchi
  • Carina—location of division of the right and left main stem bronchi
  • Cilia—hairlike projections on the tracheobronchial surface lining, which aid in the movement of secretions and debris
  • Compliance—ability of the lungs to distend (eg, emphysema—lungs very compliant; fibrosis—lungs noncompliant or stiff)
  • Dead space—ventilation that does not participate in gas exchange; also known as wasted ventilation when there is adequate ventilation but no perfusion, as in pulmonary embolus or pulmonary vascular bed occlusion. Normal dead space is 150 ml.
  • Diaphragm—dome-shaped muscle; the primary muscle used for respiration (located just below the lung bases)
  • Diffusion (of gas)—movement of gases from a higher to lower concentration
  • Dyspnea—subjective sensation associated with unpleasant, uncomfortable respiratory sensations, often caused by a dissociation between motor command and mechanical response of the respiratory system such as:
    • Respiratory muscle abnormalities (hyperinflation and airflow limitation from chronic obstructive pulmonary disease [COPD]).
    • Abnormal ventilatory impedance (narrowing airways and respiratory impedance from COPD or asthma).
    • Abnormal breathing patterns (severe exercise, pulmonary congestion or edema, recurrent pulmonary emboli).
    • Arterial blood gas (ABG) abnormalities (hypoxemia, hypercarbia).
  • Hemoptysis—bleeding from the lung; main symptom is coughing up blood
  • Hypoxemia—PaO2 less than normal, which may or may not cause symptoms (Normal PaO2 is 80 to 100 mm Hg on room air.)
  • Hypoxia—insufficient oxygenation at the cellular level due to an imbalance in oxygen delivery and oxygen consumption (Usually causes symptoms reflecting decreased oxygen reaching the brain and heart.)
  • Mediastinum—compartment between lungs containing lymph and vascular tissue that separates left from right lung
  • Orthopnea—shortness of breath when in reclining position
  • Paroxysmal nocturnal dyspnea (PND)—shortness of breath with sudden onset; occurs after going to sleep in recumbent position
  • Perfusion—blood flow, carrying oxygen and CO2 that passes by alveoli
  • Pleura—membrane that covers the outside of the lung (visceral pleura) and lines the thorax (parietal pleura) that creates a potential space
  • Pulmonary circulation (bronchial circulation)—circulatory system that supplies oxygenated blood to the respiratory system
  • Respiration—gas exchange from air to blood and blood to body cells
  • Shunt—adequate perfusion without ventilation, with deoxygenated blood conducted into the systemic circulation, as in pulmonary edema, atelectasis, pneumonia, COPD
  • Surfactant—substance released by cells within the lung; maintains surface tension and keeps alveoli open allowing for better gas exchange
  • Ventilation—movement of air (gases) in and out of the lungs
  • Ventilation-perfusion ([V with dot above]/[Q with dot above]) imbalance or mismatch—imbalance of ventilation and perfusion; a cause for hypoxemia. [V with dot above]/[Q with dot above] mismatch can be due to:
    • Blood perfusing an area of the lung where ventilation is reduced or absent.
    • Ventilation of parts of lung that are not perfused.
ASSESSMENT
SUBJECTIVE DATA
Explore the patient's symptoms through characterization and history taking to help anticipate needs and plan care.
Dyspnea
  • Characteristics—Is the dyspnea acute or chronic? Has it come about suddenly or gradually? Is more than one pillow required to sleep? Is the dyspnea progressive, recurrent, or paroxysmal? Walking how far leads to shortness of breath? How does it compare to the patient's baseline level of dyspnea?
    P.202

    Ask patient to rate dyspnea on a scale of 1 to 10 scale with 1 being no dyspnea and 10 being the worst imaginable. What relieves and what aggravates the dyspnea?
  • Associated factors—Is there a cough associated with the dyspnea and is it productive? What activities precipitate the shortness of breath? Does it seem to be worse when upset? Is it influenced by the time of day, seasons and/or certain environments? Does it occur at rest or with exertion? Any fever, chills, night sweats? Any change in body weight?
  • History—Is there a patient history or family history of chronic lung disease, cardiac or neuromuscular disease? What is the smoking history?
  • Significance—Sudden dyspnea could indicate pulmonary embolus, pneumothorax, myocardial infarction, acute ventricular failure, or acute respiratory failure. In a postsurgical or postpartum patient, dyspnea may indicate pulmonary embolus or edema. Orthopnea can be indicative of heart disease or COPD. If dyspnea is associated with a wheeze, consider asthma, COPD, or heart failure.
Chest Pain
  • Characteristics—Is the pain sharp, dull, stabbing, or aching? Is it intermittent or persistent? Is the pain localized or does it radiate? If it radiates, where? How intense is the pain? Are there factors that alleviate or aggravate the pain, such as position or activity?
  • Associated factors—What effect do inspiration and expiration have on the pain? What other symptoms accompany the chest pain? Is there diaphoresis, shortness of breath, nausea?
  • History—Is there a smoking history or environmental exposure? Has the pain ever been experienced before? What was the cause? Is there a preexisting pulmonary or cardiac diagnosis?
  • Significance—Chest pain related to pulmonary causes is usually felt on the side where pathology arises, but it can be referred. Dull persistent pain may indicate carcinoma of the lung, whereas sharp stabbing pain usually arises from the pleura.
Cough
  • Characteristics—Is the cough dry, hacking, wheezy, or more like clearing the throat? Is it strong or weak? How frequent is it? Is it worse at night or at any time of day? Is it aggravated by food intake or exertion; is it alleviated by any medication? How long has it been going on?
  • Associated factors—Is the cough productive? If so, what is the consistency, amount, color, and odor of the sputum? How does sputum compare to the patient's baseline? Is it associated with shortness of breath or pain?
  • History—Has there been any environmental or occupational exposure to dust, fumes, or gases that could lead to cough? Is there a smoking history? Is the smoking current or in past? Are there past pulmonary diagnoses, asthma, rhinitis, allergy or exposure to allergens such as pollen, house dust mites, animal dander, mold, cockroach waste, irritants (smoke, odors, perfumes, cleaning products, exhaust, pollution, cold air)? Does the patient have a history of acid reflux or use an angiotensin-converting enzyme (ACE) inhibitor whose major adverse effect is cough?
  • Significance—A dry, irritative cough may indicate viral respiratory tract infection. A cough at night should alert to potential left-sided heart failure, asthma, or just postnasal drip worsening at night. A morning cough with sputum might be bronchitis. A severe or changing cough should be evaluated for bronchogenic carcinoma. Consider bacterial pneumonia if sputum is rusty, and lung tumor if it is pink-tinged. A profuse pink frothy sputum could be indicative of pulmonary edema. A cough associated with food intake could indicate problems with aspiration. A dry cough may be associated with pulmonary fibrosis.
Hemoptysis
  • Characteristics—Is the blood from the lungs? It could be from gastrointestinal system (hematemesis) or upper airway (epistaxis). Is it bright red and frothy? How much? Is onset associated with certain circumstances or activities? Was the onset sudden, and is it intermittent or continuous?
  • Associated factors—Was there an initial sensation of tickling in the throat? Was there a salty taste, burning or bubbling sensation in the chest before bleeding? Has there been shortness of breath, chest pain, difficulty with exertion?
  • History—Was there any recent chest trauma or respiratory treatment (chest percussion)? Does the patient have an upper respiratory infection, sinusitis, or recent epistaxis?
  • Significance—Hemoptysis can be linked to pulmonary infection, lung carcinoma, abnormalities of the heart or blood vessels, pulmonary artery or vein abnormalities, or pulmonary emboli and infarction. Small amounts of blood-tinged sputum may be from the upper respiratory tract, and regurgitation of blood comes from a GI bleed.
PHYSICAL EXAMINATION
Perform a physical examination of the chest using inspection, palpation, percussion, and auscultation to determine respiratory status and differentiate primary lung problems from cardiac problems.
Key Observations
  • What is the respiratory rate, depth, and pattern? Are accessory muscles being used? Is sputum being raised, and what does it look like?
  • Is there an increase in the anterior to posterior chest diameter, suggesting air trapping?
  • Is there clubbing of the fingers, associated with bronchiectasis, lung abscess, empyema, cystic fibrosis, pulmonary neoplasms, and various other disorders?
  • Is there central cyanosis indicating possible hypoxemia or cardiac disease?
    P.203

  • Are the jugular veins distended? Is there peripheral edema or other signs of cardiac dysfunction?
  • Does palpation of the chest cause pain? Is chest expansion symmetric? Any change in tactile fremitus?
  • Is percussion of lung fields resonant bilaterally? Is diaphragmatic excursion equal bilaterally?
  • Are the lung fields clear or are there rhonchi, wheezing, or crackles? Are breath sounds equal bilaterally?.
DIAGNOSTIC TESTS
LABORATORY STUDIES
Arterial Blood Gas Analysis
Description
  • A measurement of oxygen, CO2, and the pH of the blood that provides a means of assessing the adequacy of ventilation (Paco2), oxygenation (PaO2).
  • Allows assessment of the acid-base (pH) status of the body—whether acidosis or alkalosis is present, whether acidosis or alkalosis is respiratory or metabolic in origin and to what degree (compensated or uncompensated).
  • Allows evaluation of response to clinical interventions and diagnostic evaluation (oxygen therapy, exercise testing).
Nursing and Patient Care Considerations
  • Blood can be obtained from any artery but is usually drawn from the radial, brachial, or femoral site. It can be drawn directly by arterial puncture or accessed by way of indwelling arterial catheter (see Procedure Guidelines 10-1, pages 204 to 206). Determine facility policy for qualifications for ABG sampling and site of arterial puncture.
  • If the radial artery is used, an Allen test must be performed before the puncture to determine if collateral circulation is present.
  • Arterial puncture should not be performed through a lesion, through or distal to a surgical shunt, or in area where peripheral vascular disease or infection is present.
  • Coagulopathy or medium- to high-dose anticoagulation therapy may be a relative contraindication for arterial puncture.
  • Interpret ABG values by looking at the following (normal values are listed):
    • PaO2—partial pressure of arterial oxygen (80 to 100 mm Hg)
    • Paco2—partial pressure of arterial carbon dioxide (35 to 45 mm Hg)
    • Sao2—arterial oxygen saturation (> 95%)
    • pH—hydrogen ion concentration, or degree of acid-base balance (7.35 to 7.45); bicarbonate (HCO3-) ion primarily a metabolic buffer—22 to 26 mEq/L.
Sputum Examination
Description
  • Sputum may be obtained for evaluation of gross appearance, microscopic examination, Gram's stain, culture, acid-fast bacillus, and cytology.
    • The direct smear shows presence of white blood cells and intracellular (pathogenic) bacteria and extracellular (mostly nonpathogenic) bacteria.
    • The sputum culture is used to make a diagnosis, determine drug sensitivity, and serve as a guide for drug treatment (ie, choice of antibiotic).
    • Cytology examination identifies abnormal and possibly malignant cells.
Nursing and Patient Care Considerations
  • Patients receiving antibiotics, steroids, and immunosuppressive agents for prolonged time may have periodic sputum examinations, because these agents may give rise to opportunistic pulmonary infections.
  • It is important that the sputum be collected correctly and that the specimen be sent to a laboratory immediately. Allowing it to stand in a warm room will result in overgrowth of organisms, making identification of pathogen difficult; this also alters cell morphology.
  • Sputum can be obtained by various methods:
    • Deep breathing and coughing
      • Obtain early morning specimen—yields best sample of deep pulmonary secretions from all lung fields.
      • Have patient clear nose and throat and rinse mouth—to decrease contamination by oral and upper respiratory flora.
      • Instruct patient to take several deep breaths, exhale, and perform a series of short coughs.
      • Have patient cough deeply and expectorate the sputum into a sterile container.
    • Ultrasonic or hypertonic saline nebulization
      • Patient inhales through mouth slowly and deeply for 10 to 20 minutes.
      • Nebulization increases the moisture content of air going to lower tract; particles will condense on tracheobronchial tree and aid in expectoration.
    • Tracheal suction—aspiration of secretions through endotracheal (ET) or tracheostomy tube
    • Bronchoscopic removal—provides sputum sampling by aspiration of secretions; brushing through a sterile catheter; bronchoalveolar lavage; and transbronchial biopsy
    • Gastric aspiration (rarely necessary since advent of ultrasonic nebulizer)
      • Nasogastric tube is inserted into the stomach to siphon out swallowed pulmonary secretions.
      • Useful only for culture of tubercle bacilli, but not for direct examination
      P.204

      P.205

      P.206

    • Transtracheal aspiration (see Procedure Guidelines 10-2) involves passing a needle and then a catheter through a percutaneous puncture of the cricothyroid membrane. Transtracheal aspiration bypasses the oropharynx and avoids specimen contamination by mouth flora.
Pleural Fluid Analysis
Description
  • Pleural fluid is continuously produced and reabsorbed, with a thin layer normally in the pleural space. Abnormal pleural fluid accumulation (effusion) occurs in diseases of the pleura, heart, or lymphatics. The pleural fluid is studied, with other tests, to determine the underlying cause.
  • Obtained by aspiration (thoracentesis) or by tube thoracotomy (chest tube insertion; see Procedure Guidelines 10-3, pages 209 to 211).
  • The fluid is examined for cell count, differential, specific gravity, cytology, protein, glucose, pH, lactate dehydrogenase, and amylase. Pleural fluid is usually light straw colored.
Nursing and Patient Care Considerations
  • Observe and record total amount of fluid withdrawn, nature of fluid, and its color and viscosity.
  • Prepare sample of fluid and ensure transport to the laboratory.
RADIOLOGY AND IMAGING
Chest X-Ray
Description
  • Normal pulmonary tissue is radiolucent and appears black on film. Thus, densities produced by tumors, foreign bodies, infiltrates, can be detected as lighter or white images.
  • This test shows the position of normal structures, displacement, and presence of abnormal shadows. It may reveal pathology in the lungs in the absence of symptoms.
Nursing and Patient Care Considerations
  • Should be taken upright if patient's condition permits. Assist technician at bedside in preparing patient for portable chest X-ray.
  • Encourage patient to take deep breath, hold breath, and remain still as X-ray is taken.
  • Make sure that all jewelry, electrocardiogram (ECG) leads or metal objects in X-ray field are removed so as not to interfere with film.
  • Consider the contraindication of X-rays for pregnant patients.
Computed Tomography Scan
Description
  • An imaging method in which the lungs are scanned in successive layers by a narrow X-ray beam. A computer printout is obtained of the absorption values of the tissues in the plane that is being scanned.
  • It may be used to define pulmonary nodules, pulmonary abnormalities, or to demonstrate mediastinal abnormalities and hilar adenopathy.
Nursing and Patient Care Considerations
  • Describe test to patient and family. Test takes about 30 minutes.
  • Be alert to allergies to iodine or other radiographic contrast media that might be used during testing.
  • Consider the contraindication of X-rays for the pregnant patient, especially for computed tomography (CT) scans with contrast media.
Magnetic Resonance Imaging
Description
  • A type of emission tomography based on magnetizing patient tissue, generating a weak electromagnetic signal, and mapping that signal for visualization.
  • Provides contrast between various soft tissues.
    P.207

    P.208

  • Traditional radiographic contrast media are not used but gadolinium injection may be necessary, depending on the patient's medical history and anatomy to be imaged
  • It is helpful to synchronize the magnetic resonance imaging (MRI) picture to the ECG in thoracic studies.
  • The hazards of MRI during pregnancy are unknown. X-ray radiation is not used during MRI.
Nursing and Patient Care Considerations
  • Explain procedure to patient and assess ability to remain still in a closed space; sedation may be necessary if the patient is claustrophobic.
  • Evaluate patient for contraindications to MRI: implanted devices such as pacemakers and neurostimulators that may malfunction; metallic implants such as prosthetic valves or joints, or metallic surgical clips that may move out of place.
  • Check with MRI technician about the use of equipment, such as ventilator or mechanical I.V. pump, in MRI room.
  • Evaluate the patient for claustrophobia, and teach relaxation techniques to use during test. Sedation may be necessary.
Pulmonary Angiography
Description
  • An imaging method used to study the pulmonary vessels and the pulmonary circulation.
  • For visualization, radiopaque medium is injected by way of a catheter in the main pulmonary artery rapidly into the vasculature of the lungs. Films are then taken in rapid succession after injection.
  • It is considered the “gold standard” for diagnosis of pulmonary embolus, but spiral CT scanning can also be effectively used.
Nursing and Patient Care Considerations
  • Determine whether patient is allergic to radiographic contrast media, describe the procedure, and obtain informed consent.
  • Instruct patient that injection of dye may cause flushing, cough, and a warm sensation.
  • After the procedure, make sure pressure is maintained over access site and monitor pulse rate, blood pressure, and circulation distal to the injection site.
Ventilation-Perfusion Scan
Description
  • Radioisotope imaging of ventilation and blood flow to the lungs. The scintillation camera may be interfaced to a computer to record, collate, and refine data.
  • Perfusion scan is done after injection of a radioactive isotope.
    • Measures blood perfusion through the lungs; evaluates lung function on a regional basis.
    • Useful in perfusion (vascular) abnormalities such as pulmonary embolism.
  • [V with dot above]/[Q with dot above] scan is done after inhalation of radioactive gas (xenon, krypton), which diffuses throughout the lungs.
    P.209

    P.210

    P.211

    • Useful in detecting ventilation abnormalities such as emphysema.
Nursing and Patient Care Considerations
  • Determine if patient is allergic to radiographic dye before [V with dot above]/[Q with dot above] scan.
  • Explain the procedure to the patient and encourage cooperation with inhalation and brief episodes of breath holding.
OTHER DIAGNOSTIC TESTS
Bronchoscopy
Description
  • The direct inspection and observation of the larynx, trachea, and bronchi through flexible or rigid bronchoscope.
    • Flexible fiber-optic bronchoscope allows for more patient comfort and better visualization of smaller airways.
    • Rigid bronchoscopy is preferred for small children and endobronchial tumor resection.
  • Has diagnostic and therapeutic uses in pulmonary conditions. Diagnostic uses include:
    • Collecting secretions for cytologic/bacteriologic studies.
    • Determining location and extent of pathologic process and obtaining tissue or brush biopsy for cytologic examination or culture.
    • Determining whether a tumor can be resected surgically.
    • Diagnosing bleeding sites (source of hemoptysis).
  • Therapeutic uses include removal of foreign bodies or thickened secretions from tracheobronchial tree and the excision of lesions.
Nursing and Patient Care Considerations
  • Check that an informed consent form has been signed and that risks and benefits have been explained to the patient.
  • Review and follow facility policy and procedure for conscious sedation.
  • Administer prescribed medication to reduce secretions, block the vasovagal reflex, gag reflex, and relieve anxiety. Give encouragement and nursing support.
  • Restrict fluid and food for 6 to 12 hours before procedure (to reduce risk of aspiration when reflexes are blocked).
  • Remove dentures, contact lenses, and other prostheses.
    P.212

  • After the procedure:
    • Monitor cardiac rhythm and rate, blood pressure, and level of consciousness.
    • Withhold ice chips and fluids until patient demonstrates gag reflex.
    • Monitor respiratory effort and rate.
    • Monitor oximetry.
  • Promptly report cyanosis, hypoventilation, hypotension, tachycardia or dysrhythmia, hemoptysis, dyspnea, decreased breath sounds.
Lung Biopsy
Description
  • Procedures used for obtaining histologic material from the lung to aid in diagnosis. These include:
    • Transbronchoscopic biopsy—biopsy forceps inserted through bronchoscope and specimen of lung tissue obtained.
    • Transthoracic needle aspiration biopsy—specimen obtained through needle aspiration under fluoroscopic guidance.
    • Open lung biopsy—specimen obtained through small anterior thoracotomy; used in making a diagnosis when other biopsy methods have not been effective or are not possible.
Nursing and Patient Care Considerations
  • Obtain permission for consent, if required.
  • Observe for possible complications including pneumothorax, hemorrhage (hemoptysis), and bacterial contamination of pleural space.
  • See bronchoscopy (page 211) or thoracic surgeries (page 269) for postprocedure care.
Pulmonary Function Tests
Description
  • Pulmonary function tests (PFTs) are used to detect and measure abnormalities in respiratory function, and quantify severity of various lung diseases. Such tests include measurements of lung volumes, ventilatory function, diffusing capacity, gas exchange, lung compliance, airway resistance, and distribution of gases in the lung.
  • Ventilatory studies (spirometry) are the most common group of tests.
    • Requires electronic spirometer, water spirometer, or wedge spirometer that plots volume against time (timed vital capacity).
    • Patient is asked to take as deep a breath as possible and then to exhale into spirometer as completely and as forcefully as possible.
    • Results are compared with normals for patient's age, height, and sex (see Table 10-1).
      TABLE 10-1 Pulmonary Function Tests
      TERM SYMBOL DESCRIPTION REMARKS
      Vital capacity VC Maximum volume of air exhaled after a maximum inspiration
      • VC < 10-15 mL/kg suggests need for mechanical ventilation
      • VC > 10-15 mL/kg suggests ability to wean
      Forced vital capacity FVC Vital capacity performed with a maximally forced expiratory effort
      • Reduced in obstructive disease (COPD) due to air trapping and restrictive disease
      • Reflects airflow in large airways
      Forced expiratory volume in 1 second FEV1 Volume of air exhaled in the first second of the performance of the FVC
      • Reduced in obstructive disease (COPD) due to air trapping
      • Reflects airflow in large airways
      Ratio of FEV1/FVC FEV1/FVC FEV1 expressed as a percentage of the FVC
      • Decreased in obstructive disease
      • Normal in restrictive disease
      Forced midexpiratory flow FEF 25%-75% Average flow during the middle half of the FVC
      • Reflects airflow in small airways
      • Smokers may have change in this test before other symptoms develop
      Peak expiratory flow rate PEFR Most rapid flow during a forced expiration after a maximum inspiration
      • Used to measure response to bronchodilators, airflow obstruction in patients with asthma
      Maximal voluntary ventilation MVV Volume of air expired in a specified period (12 seconds) during repetitive maximal effort
      • An important factor in exercise tolerance
      • Decreases in neuromuscular diseases
    • A reduction in the vital capacity, inspiratory capacity, and total lung capacity may indicate a restrictive form of lung disease (disease due to increased lung stiffness).
      P.213

    • An increase in functional reserve capacity, total lung capacity, and reduction in flow rates usually indicate an obstructive flow due to bronchial obstruction or loss of lung elastic recoil.
  • Lung volumes are determined by asking the patient to inhale a known concentration of inert gas such as helium or 100% oxygen and measuring concentration of inert gas or nitrogen in exhaled air (dilution method) or by plethysmography.
    • Yields thoracic volume (total lung capacity, plus any unventilated blebs or bullae).
    • An increased residual volume is found in air-trapping due to obstructive lung disease.
    • A reduction in several parameters usually indicates a restrictive form of lung disease or chest wall abnormality.
  • Diffusing capacity measures lung surface effective for the transfer of gas in the lung by having patient inhale gas containing known low concentration of carbon monoxide and measuring carbon monoxide concentration in exhaled air. Difference between inhaled and exhaled concentrations is related directly to uptake of carbon monoxide across alveolar-capillary membrane.
    • Is reduced in interstitial lung disease, emphysema, pneumonectomy, pulmonary embolus, and anemia.
Nursing and Patient Care Considerations
  • Instruct patient in correct technique for completing PFTs; coach patient through test, if needed.
  • Instruct patient not to use oral or inhaled bronchodilator (eg, albuterol), caffeine, or tobacco at least 4 hours before test (longer for long-acting bronchodilators).
Pulse Oximetry
Description
  • Provides an estimate of arterial oxyhemoglobin saturation by using selected wavelengths of light to noninvasively determine the saturation of oxyhemoglobin. Oximeters function by passing a light beam through a vascular bed, such as the finger or earlobe, to determine the amount of light absorbed by oxygenated (red) and deoxygenated (blue) blood.
  • Calculates the amount of arterial blood that is saturated with oxygen (Sao2) and displays this as a digital value.
  • Indications include:
    • Monitor adequacy of oxygen saturation; quantify response to therapy.
    • Monitor unstable patient who may experience sudden changes in blood oxygen level.
    • Evaluation of need for home oxygen therapy.
    • Determine supplemental oxygen needs at rest, with exercise, and during sleep.
    • Need to follow the trend and need to decrease number of ABG sample drawn.
  • The oxyhemoglobin dissociation curve allows for correlation between Sao2 and PaO2 (see Figure 10-1).
    FIGURE 10-1 The oxyhemoglobin dissociation curve shows the relation between the partial pressure of oxygen and the oxygen saturation. At pressures greater than 60 mm Hg, the curve is essentially flat with blood oxygen content not changing with increases in the oxygen partial pressure. As oxygen partial pressures decrease in the slope of the curve, the oxygen is unloaded to peripheral tissue as the hemoglobin's affinity decreases. The curve is shifted to the right by an increase in temperature, 2,3-DPG, or Paco2, or a decrease in pH, and to the left by the opposite of these conditions.
    • Increased body temperature, acidosis, and increased 2,3- DPG cause a shift in the curve to the right, thus increasing the ability of hemoglobin to release oxygen to the tissues.
    • Decreased temperature, decreased 2,3-DPG, and alkalosis cause a shift to the left, causing hemoglobin to hold on to the oxygen, reducing the amount of oxygen being released to the tissues.
    P.214

  • Increased bilirubin, increased carboxyhemoglobin, low perfusion or Sao2 < 80% may alter light absorption and interfere with results
Nursing and Patient Care Considerations
  • Assess patient's hemoglobin. Sao2 may not correlate well with PaO2 if hemoglobin is not within normal limits.
  • Remove patient's nail polish because it can affect the ability of the sensor to correctly determine oxygen saturation, particularly polish with blue or dark colors.
  • Correlate oximetry with ABG values and then use for single reading or trending of oxygenation (does not monitor Paco2).
  • Display heart rate should correlate with patient's heart rate.
  • To improve quality of signal, hold finger dependent and motionless (motion may alter results) and cover finger sensor to occlude ambient light.
  • Assess site of oximetry monitoring for perfusion on a regular basis, because pressure ulcer may occur from prolonged application of probe.
  • Device limitations include motion artifact, abnormal hemoglobins (carboxyhemoglobin and methemoglobin), I.V. dye, exposure of probe to ambient light, low perfusion states, skin pigmentation, nail polish or nail coverings, and nail deformities such as severe clubbing.
  • Document inspired oxygen or supplemental oxygen and type of oxygen delivery device.
  • Accuracy can be affected by ambient light, I.V. dyes, nail polish, deeply pigmented skin, patients in sickle cell crisis, jaundice, severe anemia, and use of antibiotics such as sulfas.
Capnography
Description
  • Used to determine and monitor end-tidal carbon dioxide (ETCO2)—the amount of CO2 that is expired with each breath.
  • ETCO2 is displayed as a capnogram (a waveform and numeric reading).
  • Normally 3 to 8 mm Hg less than Paco2, with the difference being greater in the presence of lung disease, or increase in dead space.
  • Being increasingly used in the critical care setting, and as a pocket-sized model in the emergency department.
Nursing and Patient Care Considerations
  • Draw ABGs initially to correlate ETCO2 with Paco2 and to establish the gradient between Paco2 and ETCO2.
  • Does not evaluate pH or oxygenation.
  • Effective for confirming ET tube placement and for monitoring CO2 in patients who tend to retain CO2 (COPD).
GENERAL PROCEDURES AND TREATMENT MODALITIES
ARTIFICIAL AIRWAY MANAGEMENT
Airway management may be indicated in patients with loss of consciousness, facial or oral trauma, copious respiratory secretions, respiratory distress, and the need for mechanical ventilation.
Types of Airways
  • Oropharyngeal airway—curved plastic device inserted through the mouth and positioned in the posterior pharynx to move tongue away from palate and open the airway
    • Usually for short-term use in the unconscious patient, or may be used along with an oral ET tube.
    • Not used if recent oral trauma, surgery, or loose teeth are present.
    • Does not protect against aspiration.
  • Nasopharyngeal airway (nasal trumpet)—soft rubber or plastic tube inserted through nose into posterior pharynx
    • Facilitates frequent nasopharyngeal suctioning.
    • Use extreme caution with patients on anticoagulants or bleeding disorders.
    • Select size that is slightly smaller than diameter of nostril and slightly longer than distance from tip of nose to earlobe.
    • Check nasal mucosa for irritation or ulceration, and clean airway with hydrogen peroxide and water.
  • ET tube—flexible tube inserted through the mouth or nose and into the trachea beyond the vocal cords that acts as an artificial airway
    • Allows for deep tracheal suction and removal of secretions.
    • Permits mechanical ventilation.
    • Inflated balloon seals off trachea so aspiration from the GI tract cannot occur.
    • Generally easy to insert in an emergency, but maintaining placement is more difficult so this is not for long-term use.
  • Tracheostomy tube—firm, curved artificial airway inserted directly into the trachea at the level of the second or third tracheal ring through a surgically made incision
    • Permits mechanical ventilation and facilitates secretion removal.
    • Can be for long-term use.
      P.215

    • Bypasses upper airway defenses, increasing susceptibility to infection.
Endotracheal Tube Insertion
  • Orotracheal insertion is technically easier, because it is done under direct visualization (see Procedure Guidelines 10-4, pages 217 to 219). Disadvantages are increased oral secretions, decreased patient comfort, difficulty with tube stabilization, and inability of patient to use lip movement as a communication means.
  • Nasotracheal insertion may be more comfortable to the patient and is easier to stabilize.
    • Disadvantages are that blind insertion is required; possible development of pressure necrosis of the nasal airway, sinusitis, and otitis media.
  • Tube types vary according to length and inner diameter, type of cuff, and number of lumens.
    • Usual sizes for adults are 6.0, 7.0, 8.0, and 9.0 mm.
    • Most cuffs are high volume, low pressure, with self-sealing inflation valves, or the cuff may be of foam rubber (Fome-Cuff).
    • Most tubes have a single lumen; however, dual-lumen tubes may be used to ventilate each lung independently (see Figure 10-2).
      FIGURE 10-2 (A) Endotrachial tubes: single lumen and double lumen endotracheal tube. When the double lumen tube is used (B), two cuffs are inflated. One cuff (1) is positioned in the trachea and the second cuff (2) in the left mainstem bronchus. After inflation, air flows through an opening below the tracheal cuff (3) to the right lung and through an opening below the bronchial cuff (4) to the left lung. This permits differential ventilation of both lungs, lavage of one lung, or selective inflation of either lung during thoracic surgery. (Marshall, B. E., Longnecker, D. E., & Fairley, H. B. [Eds.]. [1988]. Anesthesia for thoracic procedures [p. 381]. Boston: Blackwell Scientific Publications.)
  • May be contraindicated when glottis is obscured by vomitus, bleeding, foreign body, or trauma, or cervical spine injury or deformity.
Tracheostomy Tube Insertion
  • Tube types vary according to presence of inner cannula and presence and type of cuff (see Figure 10-3, page 216).
    FIGURE 10-3 Types of tracheostomy tubes. (Courtesy of Mallinckrodt Medical, St. Louis, MO.)
    • Tubes with high-volume, low-pressure cuffs with self-sealing inflation valves; with or without inner cannula
    • Fenestrated tube
    • Foam-filled cuffs (Fome-Cuff)
    • Speaking tracheostomy tube
    • Tracheal button or Passy-Muir valve
    • Silver tube (rarely used)
  • Vary according to length and inner diameter in millimeters. Usual sizes for an adult are 6.0, 7.0, 8.0, and 9.0 mm.
  • Tracheostomy is usually planned, either as an adjunct to therapy for respiratory dysfunction or for longer-term airway management when ET intubation has been used for more than 14 days.
  • May be done at the bedside in an emergency when other means of creating an airway have failed (see Procedure Guidelines 10-5, pages 220 and 221).
Indications for Endotracheal Intubation or Tracheostomy
  • Acute respiratory failure, CNS depression, neuromuscular disease, pulmonary disease, chest wall injury
  • Upper airway obstruction (tumor, inflammation, foreign body, laryngeal spasm)
  • Anticipated upper airway obstruction from edema or soft tissue swelling due to head and neck trauma, some postoperative head and neck procedures involving the airway, facial or airway burns, decreased level of consciousness
  • Aspiration prophylaxis
  • Fracture of cervical vertebrae with spinal cord injury; requiring ventilatory assistance.
Complications of Endotracheal or Tracheostomy Tubes
  • Laryngeal or tracheal injury
    • Sore throat, hoarse voice
    • Glottic edema
    • Ulceration or necrosis of tracheal mucosa
    • Vocal cord ulceration, granuloma, or polyps
    • Vocal cord paralysis
    • Postextubation tracheal stenosis
    • Tracheal dilation
    • Formation of tracheal-esophageal fistula
    • Formation of tracheal-arterial fistula
    • Innominate artery erosion
    P.216

  • Pulmonary infection and sepsis
  • Dependence on artificial airway.
Nursing Care for Patients with Artificial Airways
General Care Measures
  • Ensure adequate ventilation and oxygenation through the use of supplemental oxygen or mechanical ventilation as indicated.
  • Assess breath sounds every 2 hours. Note evidence of ineffective secretion clearance (rhonchi, crackles), which suggests need for suctioning.
  • Provide adequate humidity when the natural humidifying pathway of the oropharynx is bypassed.
  • Provide adequate suctioning of oral secretions to prevent aspiration and decrease oral microbial colonization.
  • Use clean technique when inserting an oral or nasopharyngeal airway, and take it out and clean it with hydrogen peroxide and rinse with water at least every 8 hours.
  • Perform frequent oral care with soft toothbrush or swabs and antiseptic mouthwash or hydrogen peroxide diluted with water. Frequent oral care will aid in prevention of ventilator-associated pneumonia.
  • Ensure that aseptic technique is maintained when inserting an ET or tracheostomy tube. The artificial airway bypasses the upper airway, and the lower airways are sterile below the level of the vocal cords.
  • Elevate the patient to a semi-Fowler's or sitting position, when possible; these positions result in improved lung compliance. The patient's position, however, should be changed at least every 2 hours to ensure ventilation of all lung segments and prevent secretion stagnation and atelectasis. Position changes are also necessary to avoid skin breakdown.
  • If an oral or nasopharyngeal airway is used, turn the patient's head to the side to reduce the risk of aspiration (because there is no cuff to seal off the lower airway).
Nutritional Considerations
  • Consciousness is usually impaired in the patient with an oropharyngeal airway, so oral feeding is contraindicated.
  • To enhance comfort, remove a nasopharyngeal airway in the conscious patient during mealtime.
  • Recognize that an ET tube holds the epiglottis open. Therefore, only the inflated cuff prevents the aspiration of oropharyngeal contents into the lungs. The patient must not receive oral feeding. Administer enteral tube feedings or parenteral feedings as ordered.
  • Administer oral feedings to a conscious patient with a tracheostomy, usually with the cuff inflated. The inflated cuff
    P.217


    P.218


    P.219

    prevents aspiration of food contents into the lungs, but causes the tracheal wall to bulge into the esophageal lumen, and may make swallowing more difficult.
    Patients who are not on mechanical ventilation and are awake, alert, and able to protect the airway are candidates for eating with the cuff deflated.
  • To assess ability to protect the airway, sit the patient upright and feed the patient colored gelatin or juice. If color from gelatin can be suctioned from the tracheostomy tube, aspiration is occurring, and the cuff must be inflated during feeding and for 1 hour afterward with head of bed elevated.
  • Patients should receive thickened rather than regular liquids; this will assist in effective swallowing.
Cuff Maintenance
  • ET tube cuffs should be inflated continuously and deflated only during intubation, extubation, and tube repositioning.
    P.220

    P.221

    P.222

  • Tracheostomy tube cuffs also should be inflated continuously in patients on mechanical ventilation or continuous positive airway pressure (CPAP).
  • Tracheostomized patients who are breathing spontaneously may have the cuff inflated continuously (in the patient with decreased level of consciousness without ability to fully protect airway), deflated continuously, or inflated only for feeding if the patient is at risk of aspiration.
  • Monitor cuff pressure every 4 hours (see Procedure Guidelines 10-6).
External Tube Site Care
  • Secure an ET tube so it cannot be disrupted by the weight of ventilator or oxygen tubing or by patient movement.
    • Use strips of adhesive tape or Velcro straps wrapped around the tube and secured to tape on the patient's cheeks or around the back of patient's head.
    • Replace when soiled or insecure or when repositioning of tube is necessary.
    • Position tubing so traction is not applied to ET tube.
  • Perform tracheostomy site care at least every 8 hours using hydrogen peroxide and water, and change tracheostomy ties at least once a day (see Procedure Guidelines 10-7, pages 225 to 228).
    • Make sure ventilator or oxygen tubing is supported so traction is not applied to the tracheostomy tube.
  • Have available at all times at the patient's bedside a replacement ET tube in the same size as patient is using, resuscitation bag, oxygen source, and mask to ventilate the patient in the event of accidental tube removal. Anticipate your course of action in such an event.
    • ET tube—know location and assembly of reintubation equipment including replacement ET tube. Know how to contact someone immediately for reintubation.
    • Tracheostomy—have extra tracheostomy tube, obturator, and hemostats at bedside. Be aware of reinsertion technique, if policy permits, or know how to contact someone immediately for reinserting the tube.
Psychological Considerations
  • Assist patient to deal with psychological aspects related to artificial airway.
  • Recognize that patient is usually apprehensive, particularly about choking, inability to communicate verbally, inability to remove secretions, uncomfortable suctioning, difficulty in breathing, or mechanical failure.
  • Explain the function of the equipment carefully.
  • Inform patient and family that speaking will not be possible while the tube is in place, unless using a tracheostomy tube with a deflated cuff, a fenestrated tube, a Passy-Muir speaking valve, or a speaking tracheostomy tube.
    • A Passey Muir valve is a speaking valve that fits over the end of the tracheostomy tube. Air that is inhaled is exhaled through the vocal cords and out through the mouth, allowing speech.
  • Develop with patient the best method of communication (eg, sign language, lip movement, letter boards, paper and pencil, magic slate, or coded messages).
    • Patients with tracheostomy tubes or nasal ET tubes may effectively use orally operated electrolarynx devices.
    • Devise a means for patient to get the nurse's attention when someone is not immediately available at the bedside, such as call bell, hand-operated bell, rattle.
  • Anticipate some of patient's questions by discussing “Is it permanent?” “Will it hurt to breathe?” “Will someone be with me?”
  • If appropriate, advise patient that as condition improves a tracheostomy button may be used to plug the tracheostomy site. A tracheostomy button is a rigid, closed cannula that is placed into the tracheostomy stoma after removal of a cuffed or uncuffed tracheostomy tube. When in proper position, the button does not extend into the tracheal lumen. The outer edge of the button is at the skin surface and the inner edge is at the anterior tracheal wall (see Procedure Guidelines 10-8, pages 228 and 229).
Community and Home Care Considerations
  • Teach patient and/or caregiver procedure. Patient will need to use stationary mirror to visualize tracheostomy and perform procedure.
  • Suctioning patient in the home: whenever possible, patient and/or caregiver should be taught to perform procedure. Patient should use controlled cough and other secretion clearance techniques.
  • Preoxygenation and hyperinflation before suctioning may not be routinely indicated for all patients cared for in the home. Preoxygenation and hyperinflation are based on patient need and clinical status.
  • Normal saline should not be instilled unless clinically indicated (eg, to stimulate cough).
  • Clean technique and clean examination gloves are used. At the end of suctioning, the catheter or tonsil tip should be flushed by suctioning recently boiled and cooled, or distilled, water to rinse away mucus, followed by suctioning air through the apparatus. The outer surface may be wiped with alcohol or hydrogen peroxide. The catheter and tonsil tip should be air-dried and stored in a clean, dry place. Generally, suction catheters should be discarded after 24 hours. Tonsil tips may be boiled and reused.
  • Care of tracheostomy stoma: clean with half-strength hydrogen peroxide (diluted with sterile water), and wipe with sterile water or sterile saline.

P.223


P.224


P.225


P.226


P.227


P.228


P.229

MOBILIZATION OF SECRETIONS
The goal of airway clearance techniques is to improve clearance of airway secretions, thereby decreasing obstruction of the airways. This serves to improve ventilation and gas exchange. Patients with respiratory disorders, neuromuscular disorders, or disorders, such as loss of consciousness that may impair respiratory function, typically require help with mobilization and removal of secretions. Increased amount and viscosity of secretions and/or inability to clear secretions through the normal cough mechanism may lead to pooling of secretions in lower airways. Pooling of secretions leads to infection and inadequate gas exchange. Secretions should be removed by coughing or, when necessary, by suctioning. Secretions can be mobilized through the chest physical therapy measures of postural drainage, directed cough, positive expiratory pressure, high frequency oscillation (oral devices such as Flutter or Acapella device, or chest devices such as the Vest) mucus clearance devices, autogenic drainage, intrapulmonary vibration (IPV), percussion and vibration, and other secretion clearance measures. Research shows potentially limited benefit versus risk for percussion and vibration. Breathing exercises are done with chest physical therapy to increase the efficiency of breathing.
Nasotracheal Suctioning
  • Intended to remove accumulated secretions or other materials that cannot be moved by the patient's spontaneous cough or less invasive procedures. Suctioning of the tracheobronchial tree in a patient without an artificial airway can be accomplished by inserting a sterile suction catheter lubricated with water-soluble jelly through the nares into the nasal passage, down through the oropharynx, past the glottis, and into the trachea (see Procedure Guidelines 10-9, pages 232 to 234).
  • Nasotracheal suction is a blind, high-risk procedure with uncertain outcome. Complications include mechanical trauma, hypoxia, dysrhythmias, bradycardia, increased blood pressure, vomiting, increased intracranial pressure (ICP), and misdirection of catheter.
  • Contraindications include:
    • Bleeding disorders such as disseminated intravascular coagulation, thrombocytopenia, leukemia.
    • Laryngeal edema, laryngeal spasm.
    • Esophageal varices.
    • Tracheal surgery.
    • Gastric surgery with high anastomosis.
    • Myocardial infarction.
    • Occluded nasal passages or nasal bleeding.
    • Epiglottitis.
    • Head, facial, or neck injury.
  • May cause trauma to the nasal passages.
    • Do not attempt to force the catheter if resistance is met.
    • Report if significant bleeding occurs.
  • Insert a nasal airway if repeated suctioning is necessary to protect the nasal passages from trauma.
  • Be alert for signs of laryngeal edema due to irritation and trauma.
    • Stop if suctioning becomes difficult or if the patient develops new upper airway noise or obstruction.
    • Duration of the suctioning should be limited to less than 15 seconds.
Suctioning Through an Endotracheal or Tracheostomy Tube
  • Ineffective coughing may cause secretion collection in the artificial airway or tracheobronchial tree, resulting in narrowing of the airway, respiratory insufficiency, and stasis of secretions.
  • Assess the need for suctioning at least every 2 hours through auscultation of the chest.
    • Ventilation with a manual resuscitation bag will facilitate auscultation and may stimulate coughing, decreasing the need for suctioning.
    P.230

  • Maintain sterile technique while suctioning (see Procedure Guidelines 10-10, pages 234 to 236).
  • Administer supplemental 100% oxygen through the mechanical ventilator or manual resuscitation bag before, after, and between suctioning passes to prevent hypoxemia.
  • Closed system suctioning may be done with the suction catheter contained in the mechanical ventilator tubing. Ventilator disconnection is not necessary so time is saved, sterility is maintained, and risk of exposure to body fluids is eliminated.
Community and Home Care Considerations
  • Teach caregivers to suction in the home situation using clean technique, rather than sterile. Wash hands well before suctioning.
  • Put on fresh examination gloves for suctioning, and reuse catheter after rinsing it in warm water.
  • Be aware that appropriate and aggressive airway clearance will assist in preventing pulmonary complications, thus lessening the need for hospitalization.
Chest Physical Therapy
Breathing Exercises
  • Techniques used to compensate for respiratory deficits and conserve energy by increasing efficiency of breathing (see Procedure Guidelines 10-11, pages 237 and 238).
  • The overall purposes for doing breathing exercises are:
    • To relax muscles, relieve anxiety, and improve control of breathing.
    • To eliminate useless uncoordinated patterns of respiratory muscle activity.
    • To slow the respiratory rate.
    • To decrease the work of breathing.
    • To improve efficiency and strength of respiratory muscles.
    • To improve ventilation and oxygen saturation during exercise.
  • Diaphragmatic breathing is used primarily to strengthen the diaphragm, which is the main muscle of respiration. It also aids in decreasing the use of accessory muscles and allows for better control over the breathing pattern, especially during stressful situations and increased physical demands.
  • Pursed-lip breathing is used primarily to slow the respiratory rate and assist in emptying the lungs of retained CO2. This technique is always helpful to patients, but especially when they feel extreme dyspnea due to exertion.
  • Breathing exercises are most helpful to patients when practiced and used on a regular basis.
Percussion and Vibration
  • Postural drainage uses gravity and, possibly, external manipulation of the thorax to improve mobilization of bronchial secretions, to enhance matching of ventilation and perfusion, and to normalize functional residual capacity.
  • Indicated for difficulty with secretion clearance, evidence of retained secretions, and lung conditions that cause increased production of secretions such as bronchiectasis, cystic fibrosis, chronic bronchitis, and emphysema.
  • Contraindicated in undrained lung abscess, lung tumors, pneumothorax, diseases of the chest wall, lung hemorrhage, painful chest conditions, tuberculosis, severe osteoporosis, increased ICP, uncontrolled hypertension, and gross hemoptysis.
  • Percussion is movement done by “clapping” the chest wall in a rhythmic fashion with cupped hands or a mechanical device directly over the lung segments to be drained. The wrists are alternately flexed and extended so the chest is cupped or clapped in a painless manner (see Procedure Guidelines 10-12, page 239). A mechanical percussor may be used to prevent repetitive motion injury. This technique is considered by some to have limited research-based evidence of benefit versus risk.
  • Vibration is the technique of applying manual compression with oscillations or tremors to the chest wall during the exhalation phase of respiration. This technique is considered by some to have limited research-based evidence of benefit versus risk.
Postural Drainage
  • Use of specific positions so the force of gravity can assist in the removal of bronchial secretions from affected lung segments to central airways by means of coughing or suctioning (see Figure 10-4).
    FIGURE 10-4 Postural drainage positions. Anatomic segments of the lung with four postural drainage positions. The numbers relate the position to the corresponding anatomic segment of the lung.
  • The patient is positioned so the diseased areas are in a near vertical position, and gravity is used to assist drainage of the specific segments.
  • The positions assumed are determined by the location, severity, and duration of mucus obstruction.
  • The exercises are usually performed two to four times daily, before meals and at bedtime. Each position is held for 3 to 15 minutes.
  • The procedure should be discontinued if tachycardia, palpitations, dyspnea, or chest pain occurs. These symptoms may indicate hypoxemia. Discontinue if hemoptysis occurs.
  • Contraindications include increased ICP, unstable head or neck injury, active hemorrhage with hemodynamic instability or gross hemoptysis, recent spinal surgery or injury, empyema, bronchopleural fistula, rib fracture, flail chest, and uncontrolled hypertension.
  • Bronchodilators, mucolytic agents, water, or saline may be nebulized and inhaled, or an inhaled bronchodilator may be used before postural drainage and chest percussion to reduce bronchospasm, decrease thickness of mucus and sputum, and combat edema of the bronchial walls, thereby enhancing secretion removal (see Procedure Guidelines 10-13, page 240).
    P.231

  • Perform secretion clearance procedures before eating or a minimum of one hour after eating.
  • Make sure patient is comfortable before the procedure starts and as comfortable as possible while he or she assumes each position.
  • Auscultate the chest to determine the areas of needed drainage.
  • Encourage the patient to deep breathe and cough after spending the allotted time in each position (normally 3 to 15 minutes).
  • Encourage diaphragmatic breathing throughout postural drainage; this helps widen airways so secretions can be drained.
Directed Cough
  • Used to enhance effects of a spontaneous cough and compensate for physical limitations. Used for secretion clearance, atelectasis, prophylaxis against postoperative pulmonary complications, routine bronchial hygiene for cystic fibrosis, bronchiectasis, chronic bronchitis, and to obtain sputum specimen for diagnostic analysis.
  • Procedure includes a forced exhalation technique of two to three huffs (forced expirations), from mid- to low-lung volume, with glottis open, followed by a period of relaxed, controlled diaphragmatic breathing. Explain to the patient that to huff cough is the same maneuver that fogs eyeglasses. The forced expiration can be augmented by brisk adduction of the upper arms to self-compress the thorax.
  • Contraindications include increased ICP or known intracranial aneurysm, as well as acute or unstable head, neck, or spinal injury.
Manually Assisted Cough
The external application of mechanical pressure to the epigastric region coordinated with forced exhalation.
Positive Expiratory Pressure
  • Positive back pressure is created in the airways when the patient breathes in and out 5 to 20 times through a flow resistor or fixed orifice device.
  • During prolonged exhalation against positive pressure, peripheral airways are stabilized while air is pushed through collateral pathways (pores of Kohn and canals of Lambert) into distal lung units past retained secretions.
  • Expiratory airflow moves secretions to larger airways to be removed by coughing.
  • The pressure generated can be monitored and adjusted with a manometer (usually range from 10 to 20 cm H2O).
    P.232

    P.233

    P.234

    P.235

    P.236

    P.237

    P.238

    P.239

    P.240

  • Active exhalation with an inspiratory-to-expiratory ratio of 1:3 or 1:4 is suggested.
  • The cycle is repeated until secretions are expelled, usually within 20 minutes or less if patient tires.
Autogenic Drainage
  • Controlled breathing used at three lung volumes, beginning at low-lung volumes to unstick mucus, moving to mid-lung volume to collect mucus, and then to high-lung volume to expel mucus.
  • This method may be difficult for some patients to learn and to perform independently.
Flutter Mucus Clearance Device
  • Provides positive expiratory pressure (PEP) and high-frequency oscillations at the airway opening. Provides approximately 10 cm H2O positive airway pressure.
  • The flutter valve is a pipe-shaped device with an inner cone and bowl loosely supporting a steel ball. The bowl containing the steel ball is covered by a perforated cap.
    P.241

  • Indications include atelectasis, bronchitis, bronchiectasis, cystic fibrosis, and other conditions producing retained secretions.
  • Mucus clearance is based on:
    • Vibration of the airways, which loosens mucus from airway walls.
    • Intermittent increase in endobronchial pressure that keeps airways open.
    • Acceleration of expiratory airflow to facilitate upward movement of mucus.
  • Contraindications include pneumothorax and right-sided heart failure.
  • Directions:
    • Patient should be seated upright with chin tilted slightly upward to further open airway.
    • Instruct patient to inhale slowly to 3/4 of normal breath.
    • Place flutter in mouth with lips firmly sealed around stem or mouthpiece.
    • Position flutter at horizontal level or raise bulb end up to 30 degrees for greater force.
    • Instruct patient to hold breath for 2 to 3 seconds.
    • Exhale through flutter at moderately fast rate, keeping cheeks stiff. Urge to cough should be suppressed.
    • Repeat for 5 to 10 more breaths.
  • Have patient perform same technique with one to two forced exhalations to generate mucus elimination, and huff coughs as needed.
  • Generally used for 10 to 20 breaths with device followed by several directed coughs, repeating series 4 to 6 times or for 10 to 20 minutes up to four times daily.
  • Clean flutter device every other day by disassembling and using a liquid soap and tap water. Disinfect regularly by soaking cleaned disassembled parts in one part alcohol to three parts tap water for 1 minute; rinse, wipe, reassemble, and store.
Acapella Vibratory Positive Expiratory Pressure Device
  • Enhances movement of secretions to larger airways, prevents collapse of airways, and facilitates filling of collapsed alveoli.
  • Vibration provides percussive effect, disengaging mucus from airway walls, causes pulsation of mucus toward larger airways, and reduces visco-elasticity of mucus.
  • Select device: green for expiratory flow < 15 L/minute, blue for < 15 L/minute.
  • Place mask tightly and comfortably over patient's mouth and nose (or lips tight around mouthpiece if mask not used).
  • Instruct patient to perform diaphragmatic breathing, inhale to near total lung volume, exhale actively but not forcefully through device fully. Set resistance to achieve I:E ratio of 1:3 to 1:4. Use inline manometer to select expiratory pressure of 10 to 20 cm H2O.
  • Use every 1 to 6 hours, according to response.
  • Assessment: improving breath sounds, patient's report of improved dyspnea, improved chest X-ray, improved oxygenation.
  • Acapella Choice can be disassembled for cleaning in dishwasher, boiled, or autoclaved.
AeroPEP Valved Holding Chamber
  • Combines aerosol therapy from a metered dose inhaler with a fixed orifice resister PEP therapy.
  • Place disposable mouthpiece over AeroPEP mouthpiece and attach manometer. Instruct patient to seal lips tightly around mouthpiece.
  • While performing diaphragmatic breathing, inhale fully.
  • Exhale actively and fully to achieve Positive Expiratory Pressure of 10 to 20 cm H2O. Set AeroPEP between 0 and 6 at desired pressure on manometer.
  • Repeat for up to 20 minutes four times daily, or as clinically indicated.
Intrapulmonary Percussive Ventilation or Percussionaire
  • Therapy is delivered by a percussionator, which delivers mini-bursts of air into the lungs at a rate of 100 to 300 per minute. Process includes delivery of a dense aerosol mist. The treatment lasts about 20 minutes.
  • Patient uses in sitting or recumbent position.
  • Instill nebulizer bowl with 20 cc of saline or aqueous water and prescribed bronchodilator.
  • Clinician or patient programs percussive cycle by holding down a button for 5 to 10 seconds for percussive inspiratory cycle and releasing to expectorate or pause during therapy.
  • Seal lips around mouthpiece with “pucker” to minimize cheek flapping.
  • Observe chest for percussive shaking.
  • Use twice daily for approximately 20 minutes with increased frequency as needed.
The In-Exsufflator
Assists in secretion clearance by applying positive pressure to the airway, then rapidly shifting to negative pressure by way of a face mask, mouthpiece, ET tube, or tracheostomy tube.
The Vest Airway Clearance System
  • Enhances secretion clearance through high-frequency chest wall oscillation. High-frequency compression pulses are applied to the chest wall by way of an air pulse generator and inflatable vest.
  • Variable frequency large volume air pulse delivery system attached to inflatable vest. Pressure pulses that fill the vest and vibrate the chest wall are controlled by foot pedal. Pulse frequency ranges from 5 to 25 Hz and pressure in the vest ranges from 28 to 39 mm Hg.
  • A foot or hand control starts and stops pulsations.
  • Treatment length usually 10 to 30 minutes. Therapy should include a break at least every 10 minutes for directed
    P.242

    cough. Use twice daily, with increased frequency as needed.
Community and Home Care Considerations
  • Nebulizer tubing and mouthpiece can be reused at home repeatedly. Recommend thorough rinsing with hot water after each use.
  • Twice-weekly cleaning should include washing with liquid soap and hot water, followed by 30-minute soak in one part white vinegar and two parts tap water, and then rinsing with tap water, air drying, and storing in a clean, dry place.
ADMINISTERING OXYGEN THERAPY
Oxygen is an odorless, tasteless, colorless, transparent gas that is slightly heavier than air. It is used to treat or prevent symptoms and manifestations of hypoxia. Oxygen can be dispensed from a cylinder, piped-in system, liquid oxygen reservoir, or oxygen concentrator. It may be administered by nasal cannula, transtracheal catheter, nasal cannula with reservoir devices, or various types of face masks, including CPAP mask. It may also be applied directly to the ET or tracheal tube by way of a mechanical ventilator, T-piece, or manual resuscitation bag. The method selected depends on the required concentration of oxygen, desired variability in delivered oxygen concentration (none, minimal, moderate), and required ventilatory assistance (mechanical ventilator, spontaneous breathing).
Methods of Oxygen Administration
  • Nasal cannula (see Procedure Guidelines 10-14, pages 244 and 245)—nasal prongs that deliver low flow of oxygen.
    • Requires nose breathing.
    • Cannot deliver oxygen concentrations much higher than 40%.
  • Simple face mask (see Procedure Guidelines 10-15, pages 245 and 246)—mask that delivers moderate oxygen flow to nose and mouth. Delivers oxygen concentrations of 40% to 60%.
  • Venturi mask (see Procedure Guidelines 10-16, pages 247 and 248)—mask with device that mixes air and oxygen to deliver constant oxygen concentration.
    • Total gas flow at the patient's face must meet or exceed peak inspiratory flow rate. When other mask outputs do not meet inspiratory flow rate of patient, room air (drawn through mask side holes) mixes with the gas mixture provided by the face mask, lowering the inspired oxygen concentration.
    • Venturi mask mixes a fixed flow of oxygen with a high but variable flow of air to produce a constant oxygen concentration. Oxygen enters by way of a jet (restricted opening) at a high velocity. Room air also enters and mixes with oxygen at this site. The higher the velocity (smaller the opening), the more room air is drawn into the mask.
    • Mask output ranges from approximately 97 L/minute (24%) to approximately 33 L/minute (50%).
    • Virtually eliminates rebreathing of CO2. Excess gas leaves through openings in the mask, carrying with it the expired CO2.
  • Partial rebreather mask (see Procedure Guidelines 10-17, pages 248 and 249) has an inflatable bag that stores 100% oxygen.
    • On inspiration, the patient inhales from the mask and bag; on expiration, the bag refills with oxygen and expired gases exit through perforations on both sides of the mask and some enters bag (see Figure 10-5).
      FIGURE 10-5 (A) Air flow diagram with partial rebreathing mask. (B) Air flow diagram with nonrebreathing mask. Arrows indicate direction of flow.
    • High concentrations of oxygen (50% to 75%) can be delivered.
  • Nonrebreathing mask (see Procedure Guidelines 10-17, pages 248 and 249) has an inflatable bag to store 100% oxygen and a one-way valve between the bag and mask to prevent exhaled air from entering the bag.
    • Has one-way valves covering one or both the exhalation ports to prevent entry of room air on inspiration.
    • Has a flap or spring-loaded valves to permit entry of room air should the oxygen source fail or patient needs exceed the available oxygen flow.
    • Optimally, all the patient's inspiratory volume will be provided by the mask/reservoir, allowing delivery of nearly 100% oxygen.
  • Transtracheal catheter (see Procedure Guidelines 10-18, pages 250 to 252)—accomplished by way of a small (8 French) catheter inserted between the second and third tracheal cartilage.
    • Does not interfere with talking, drinking, or eating and can be concealed under a shirt or blouse.
    • Oxygen delivery is more efficient because all oxygen enters the lungs.
  • Continuous positive airway pressure (CPAP) mask (see Procedure Guidelines 10-19, pages 252 and 253) is used to provide expiratory and inspiratory positive airway pressure in a manner similar to positive end-expiratory pressure (PEEP) and without ET intubation.
    • Has an inflatable cushion and head strap designed to tightly seal the mask against the face.
    • A PEEP valve is incorporated into the exhalation port to maintain positive pressure on exhalation.
    • High inspiratory flow rates are needed to maintain positive pressure on inspiration.
  • T-piece (Briggs) adapter (see Procedure Guidelines 10-20, pages 254 and 255) is used to administer oxygen to patient with ET or tracheostomy tube who is breathing spontaneously.
    • High concentration of aerosol and oxygen delivered through wide bore tubing.
    • Expired gases exit through open reservoir tubing.
  • Manual resuscitation bag (see Procedure Guidelines 10-21, pages 255 to 257) delivers high concentration of oxygen to patient with insufficient inspiratory effort.
    • With mask, uses upper airway by delivering oxygen to mouth and nose of patient.
    • Without mask, adapter fits on ET or tracheostomy tube.
      P.243

    • Usually used in cardiopulmonary arrest, hyperinflation during suctioning, or transport of ventilator-dependent patients.
Nursing Assessment and Interventions
  • Assess need for oxygen by observing for symptoms of hypoxia:
    • Tachypnea.
    • Sao2 < 88%.
    • Tachycardia or dysrhythmias (premature ventricular contractions).
    • A change in level of consciousness (symptoms of decreased cerebral oxygenation are irritability, confusion, lethargy, and coma, if untreated).
    • Cyanosis occurs as a late sign (PaO2 ≤ 45 mm Hg).
    • Labored respirations indicate severe respiratory distress.
    • Myocardial stress—increase in heart rate and stroke volume (cardiac output) is the primary mechanism for compensation for hypoxemia or hypoxia; pupils dilate with hypoxia.
  • Obtain ABG values and assess the patient's current oxygenation, ventilation, and acid-base status.
  • Administer oxygen in the appropriate concentration.
    • Low concentration (24% to 28%) —may be appropriate for patients prone to retain CO2 (COPD, drug overdose), who are dependent on hypoxemia (hypoxic drive) to maintain respiration. If hypoxemia is suddenly reversed, hypoxic drive may be lost and respiratory depression and, possibly, respiratory arrest may occur. Monitor PaCO2 levels.
    • High concentration (≥ 30%)—if hypoxemia is suddenly reversed, hypoxic drive may be inhibited and respiratory depression and, possibly, respiratory arrest may occur. High concentrations are appropriate in patients not predisposed to CO2 retention.
  • Monitor response by oximetry and/or ABG sampling.
  • Increase or decrease the inspired oxygen concentration (FIO2), as appropriate.
Community and Home Care Considerations
  • Indications for supplemental oxygen based on Medicare reimbursement guidelines:
    • Documented hypoxemia: In adults: PaO2 = 55 torr or Sao2 ≤ 88% when breathing room air, or PaO2 56 to 59 torr or Sao2 ≤ 89% in association with cor pulmonale, heart failure, or polycythemia with hematocrit > 56%.
    • Some patients may not qualify for oxygen therapy at rest but will qualify for oxygen during ambulation, exercise, or sleep. Oxygen therapy is indicated during these specific activities when Sao2 is demonstrated to fall to ≤ 88%.
    • Determine oxygen prescription for rest, exercise, and sleep, and instruct patient and caregiver to follow these flow rates.
  • Precautions in the home
    • In COPD with presence of CO2 retention (generally due to chronic hypoxemia), oxygen administration at higher levels may lead to increased Paco2 level, and decreased respiratory drive.
      P.244

      P.245

      P.246

      P.247

      P.248

      P.249

      P.250

      P.251

      P.252

      P.253

      P.254

      P.255

      P.256

      P.257

    • Fire hazard is increased in presence of higher than normal oxygen concentrations. Instruct patient and caregiver of home oxygen precautions:
      • Post No smoking signs. Instruct in avoidance of cigarettes within 6 feet of oxygen.
      • Avoid potential electrical sparks around oxygen (shave with blade razor instead of electric razor; keep away from heat sources).
      • Keep oxygen at least 6 feet (1.8 m) from any source of flame.
    • Power failure may lead to inadequate oxygen supply when an oxygen concentrator is used without backup tank.
    • Oxygen tanks must be secured in stand to prevent falling over.
    • Improper use of liquid oxygen (touching liquid) may result in burns.
  • Oxygen delivered by way of tracheostomy collar or T-tube should be humidified.
  • Oxygen concentrators extract oxygen from ambient air and should deliver oxygen at concentrations of 85% or greater at up to 4 L/minute.
  • Liquid oxygen is provided in large reservoir canisters with smaller portable units that can be transfilled by the patient or caregiver. Liquid oxygen evaporates from canister when not in use.
  • Compressed gas may be supplied in large cylinders (G or H cylinders) or smaller cylinders (D or E cylinders) with wheels for easier movement.
  • All oxygen delivery equipment should be checked at least once daily by the patient or caregiver, including function of equipment, prescribed flow rates, remaining liquid or compressed gas content, and backup supply.
MECHANICAL VENTILATION
The mechanical ventilator device functions as a substitute for the bellows action of the thoracic cage and diaphragm. The mechanical ventilator can maintain ventilation automatically for prolonged periods. It is indicated when the patient is unable to maintain safe levels of oxygen or CO2 by spontaneous breathing even with the assistance of other oxygen delivery devices.
Clinical Indications
Mechanical Failure of Ventilation
  • Neuromuscular disease
  • Central nervous system (CNS) disease
  • CNS depression (drug intoxication, respiratory depressants, cardiac arrest)
  • Musculoskeletal disease
  • Inefficiency of thoracic cage in generating pressure gradients necessary for ventilation (chest injury, thoracic malformation)
Disorders of Pulmonary Gas Exchange
  • Acute respiratory failure
  • Chronic respiratory failure
  • Left ventricular failure
  • Pulmonary diseases resulting in diffusion abnormality
  • Pulmonary diseases resulting in ventilation-perfusion mismatch.
Underlying Principles
  • Variables that control ventilation and oxygenation include:
    • Ventilator rate—adjusted by rate setting.
      P.258

    • Tidal volume (VT)—adjusted by tidal volume setting; measured as inhaled volume.
    • Fraction inspired oxygen concentration (FIO2)—set on ventilator or with an oxygen blender; measured with an oxygen analyzer.
    • Ventilator dead space—circuitry (tubing) common to inhalation and exhalation; tubing is calibrated.
    • PEEP—set within the ventilator or with the use of external PEEP devices; measured at the proximal airway.
  • CO2 elimination is controlled by VT, rate, and dead space.
  • Oxygen tension is controlled by oxygen concentration and PEEP (also by rate and VT).
  • In most cases, the duration of inspiration should not exceed exhalation.
    • Rate, tidal volume, gas flow in liters per minute, and inspiratory pause all control inspiratory time.
    • Inverse I:E ratio results in “stacking” of breaths or buildup of pressure within the airway. Barotrauma and decreased cardiac output can result when inverse I:E ratio is used.
  • The inspired gas must be warmed and humidified to prevent thickening of secretions and decrease in body temperature. Sterile or distilled water is warmed and humidified by way of a heated humidifier.
Types of Ventilators
Negative Pressure Ventilators
  • Applies negative pressure around the chest wall. This causes intra-airway pressure to become negative, thus drawing air into the lungs through the patient's nose and mouth.
  • No artificial airway is necessary; patient must be able to control and protect own airway.
  • Indicated for selected patients with respiratory neuromuscular problems, or as adjunct to weaning from positive pressure ventilation.
  • Examples are the iron lung and cuirass ventilator.
Positive Pressure Ventilators
During mechanical inspiration, air is actively delivered to the patient's lungs under positive pressure. Exhalation is passive. Requires use of a cuffed artificial airway
  • Pressure limited
    • Terminates the inspiratory phase when a preselected airway pressure is achieved.
    • Volume delivered depends on lung compliance.
    • Use of volume-based alarms is recommended because any obstruction between the machine and lungs that allows a buildup of pressure in the ventilator circuitry will cause the ventilator to cycle, but the patient will receive no volume.
  • Volume limited
    • Terminates the inspiratory phase when a designated volume of gas is delivered into the ventilator circuit (5 to 7 mL/kg body weight—usual starting volume).
    • Delivers the predetermined volume regardless of changing lung compliance (although airway pressures will increase as compliance decreases). Airway pressures vary from patient to patient and from breath to breath.
    • Pressure-limiting valves, which prevent excessive pressure buildup within the patient-ventilator system, are used. Without this valve, pressure could increase indefinitely and pulmonary barotrauma could result. Usually equipped with a system that alarms when selected pressure limit is exceeded. Pressure-limited settings terminate inspiration when reached.
Modes of Operation
Controlled Ventilation
  • Cycles automatically at rate selected by operator.
  • Provides a fixed level of ventilation, but will not cycle or have gas available in circuitry to respond to patient's own inspiratory efforts. This typically increases work of breathing for patients attempting to breathe spontaneously.
  • Possibly indicated for patients whose respiratory drive is absent.
Assist/Control
  • Inspiratory cycle of ventilator is activated by the patient's voluntary inspiratory effort and delivers preset volume or pressure.
  • Ventilator also cycles at a rate predetermined by the operator. Should the patient stop breathing, or breathe so weakly that the ventilator cannot function as an assistor, this mandatory baseline rate will prevent apnea. A minimum respiratory rate is provided.
  • Indicated for patients who are breathing spontaneously, but who have the potential to lose their respiratory drive or muscular control of ventilation. In this mode, the patient's work of breathing is greatly reduced.
Intermittent Mandatory Ventilation
  • Allows patient to breathe spontaneously through ventilator circuitry.
  • Periodically, at preselected rate and volume or pressure, cycles to give a “mandated” ventilator breath. A minimum level of ventilation is provided.
  • Gas provided for spontaneous breaths usually flows continuously through the ventilator.
  • Indicated for patients who are breathing spontaneously, but at a tidal volume and/or rate less than adequate for their needs. Allows the patient to do some of the work of breathing.
Synchronized Intermittent Mandatory Ventilation
  • Allows patient to breathe spontaneously through the ventilator circuitry.
  • Periodically, at a preselected time, a mandatory breath is delivered. The patient may initiate the mandatory breath with own inspiratory effort, and the ventilator breath will be synchronized with the patient's efforts, or will be “assisted.” If the patient does not provide inspiratory effort, the breath will
    P.259

    still be delivered, or “controlled.”
  • Gas provided for spontaneous breathing is usually delivered through a demand regulator, which is activated by the patient.
  • Indicated for patients who are breathing spontaneously, but at a VT and/or rate less than adequate for their needs. Allows the patient to do some of the work of breathing.
Pressure Support
  • A positive pressure is set.
  • During spontaneous inspiration, ventilator circuitry is rapidly pressurized to the predetermined pressure and held at this pressure.
  • When the inspiratory flow rate decreases to a preset minimal level (20% to 25% of peak inspiratory flow), the positive pressure returns to baseline and the patient may exhale.
  • The patient ventilates spontaneously, establishing own rate, and inspiring the VT that feels appropriate.
  • Pressure support may be used independently as a ventilatory mode or used in conjunction with CPAP or synchronized intermittent madatory ventilation (SIMV).
Special Positive Pressure Ventilation Techniques
Positive End-Expiratory Pressure
  • Maneuver by which pressure during mechanical ventilation is maintained above atmospheric at end of exhalation, resulting in an increased functional residual capacity. Airway pressure is therefore positive throughout the entire ventilatory cycle.
  • Purpose is to increase functional residual capacity (or the amount of air left in the lungs at the end of expiration). This aids in:
    • Increasing the surface area of gas exchange.
    • Preventing collapse of alveolar units and development of atelectasis.
    • Decreasing intrapulmonary shunt.
  • Benefits.
    • Because a greater surface area for diffusion is available and shunting is reduced, it is often possible to use a lower FIO2 than otherwise would be required to obtain adequate arterial oxygen levels. This reduces the risk of oxygen toxicity in conditions such as acute respiratory distress syndrome (ARDS).
    • Positive intra-airway pressure may be helpful in reducing the transudation of fluid from the pulmonary capillaries in situations where capillary pressure is increased (ie, left-sided heart failure).
    • Increased lung compliance resulting in decreased work of breathing.
  • Hazards.
    • Because the mean airway pressure is increased by PEEP, venous return is impeded. This may result in a decrease in cardiac output (especially noted in hypovolemic patients).
    • There is disagreement that the increased airway pressure may possibly result in alveolar rupture. The likelihood of damage is greater from peak airway pressure during mechanical ventilation than end-expiratory pressure. The likelihood is greater in patients with noncompliant lungs. This barotrauma may result in pneumothorax, tension pneumothorax, or development of subcutaneous emphysema.
    • The decreased venous return may cause antidiuretic hormone formation to be stimulated, resulting in decreased urine output.
  • Precautions.
    • Monitor frequently for signs and symptoms of pneumothorax (increased pulmonary artery pressure, increased size of hemothorax, decreased lung movement, hyperresonant percussion, diminished breath sounds).
    • Monitor for signs of decreased venous return (decreased blood pressure, decreased cardiac output, decreased urine output, peripheral edema).
    • Abrupt discontinuance of PEEP is not recommended. The patient should not be without PEEP for longer than 15 seconds. The manual resuscitation bag used for ventilation during suction procedure or patient transport should be equipped with a PEEP device. In-line suctioning may also be used so PEEP can be maintained. Some clinicians believe that loss of PEEP for short periods is not detrimental in the lower ranges (less than 10 cm H2O). An exception might be patients with increased ICP.
    • Intrapulmonary blood vessel pressure may increase with compression of the vessels by increased intra-airway pressure. Therefore, central venous pressure (CVP), pulmonary artery pressure (PAP), and pulmonary capillary wedge pressure (PCWP) may be increased. The clinician must bear this in mind when determining the clinical significance of these pressures.
Continuous Positive Airway Pressure
  • Also provides for positive airway pressure during all parts of a respiratory cycle, but refers to spontaneous ventilation rather than mechanical ventilation.
  • May be delivered through ventilator circuitry when ventilator rate is at “0” or may be delivered through a separate continuous positive airway pressure (CPAP) circuitry that does not require the ventilator.
  • Indicated for patients who are capable of maintaining an adequate tidal volume, but who have pathology preventing maintenance of adequate levels of tissue oxygenation or for sleep apnea.
  • CPAP has the same benefits, hazards, and precautions noted with PEEP. Mean airway pressures may be lower because of lack of mechanical ventilation breaths. This results in less risk of barotrauma and impedance of venous return.
Newer Modes of Ventilation
Inverse Ratio Ventilation
  • I:E ratio is greater than 1, in which inspiration is longer than expiration.
  • Potentially used in patients who are in acute severe hypoxemic respiratory failure. Oxygenation is thought to be improved.
  • Used with heavily sedated patients.
  • Pressure-controlled inverse ratio ventilation (PC-IRV)—used in ARDS and acute lung injury.
  • Pressure-regulated volume control (PRVC) ventilator mode is a volume-targeted mode used in acute respiratory failure that combines the advantages of the decelerating inspiratory flow pattern of a pressure-control mode with the ease of use of a volume-control (VC) mode.
Noninvasive Positive Pressure Ventilation
  • Uses a nasal mask, nasal pillow, oral mask, or mouthpiece attached to a standard ventilator. Delivers air through portable ventilator that is either volume cycled or flow cycled.
  • Used primarily in the past for patients with chronic respiratory failure associated with neuromuscular disease. Now, is being used successfully during acute exacerbations. Some patients are able to avoid invasive intubation. Other indications include weaning and postextubation respiratory decompensation. Most successful with COPD.
  • Used easily in home setting. Equipment is portable and relatively easy to use.
  • May include BiPAP (bilevel positive airway pressure), which is essentially pressure support with CPAP. The system has a rate setting, as well as inspiratory and expiratory pressure setting.
High-Frequency Ventilation
  • Uses very small tidal volumes (less than dead space volume) and high frequency (ratios greater than 100).
  • Gas exchange occurs through various mechanisms, not the same as conventional ventilation (convection).
  • Types include:
    • High-frequency oscillatory ventilation (HFOV).
    • High-frequency jet ventilation (HFJV).
  • Theory is that there is decreased barotrauma by having small tidal volumes and that oxygenation is improved by constant flow of gases.
  • Successful with infant respiratory distress syndrome (IRDS), much less successful with adult pulmonary complications.
Nursing Assessment and Interventions
  • Monitor for complications.
    • Airway obstruction (thickened secretions, mechanical problem with artificial airway or ventilator circuitry)
    • Tracheal damage
    • Pulmonary infection
    • Barotrauma (pneumothorax or tension pneumothorax)
    • Decreased cardiac output
    • Atelectasis
    • Alteration in GI function (dilation, bleeding)
    • Alteration in renal function
    • Alteration in cognitive-perceptual status
    • Respiratory acidosis or alkalosis
  • Suction the patient as indicated.
    • When secretions can be seen or sounds resulting from secretions are heard with or without the use of a stethoscope
    • After chest physiotherapy
    • After bronchodilator treatments
    • After a sudden rise or the “popping off” of the peak airway pressure in mechanically ventilated patients that is not due to the artificial airway or ventilator tube kinking, the patient biting the tube, the patient coughing or struggling against the ventilator, or a pneumothorax
  • Provide routine care for patient on mechanical ventilator (see Procedure Guidelines 10-22). Provide regular oral care to prevent ventilator-associated pneumonia. Provide humidity and repositioning to mobilize secretions.
  • Assist with the weaning process, when indicated (patient gradually assumes responsibility for regulating and performing own ventilations; see Procedure Guidelines 10-23, pages 265 to 267).
    • Patient must have acceptable ABG values, no evidence of acute pulmonary pathology, and must be hemodynamically stable.
    • Obtain serial ABGs and/or oximetry readings, as indicated.
    • Monitor very closely for change in pulse and blood pressure, anxiety, and increased rate of respirations.
    • The use of anxiolytics to assist with weaning the anxious patient is controversial; they may or may not be beneficial.
  • Once weaning is successful, extubate and provide alternate means of oxygen (see Procedure Guidelines 10-24, pages 267 to 269).
  • Extubation will be considered when the pulmonary function parameters of VT, vital capacity (VC), and negative inspiratory force (NIF) are adequate, indicating strong respiratory muscle function.
Community and Home Care Considerations
Patients may require mechanical ventilation at home to replace or assist normal breathing. Ventilator support in the home is used to keep the patient clinically stable and to maintain life
  • Candidates for home ventilation are those patients who are unable to wean from mechanical ventilation, and/or have disease progression requiring ventilator support. Candidates for home mechanical ventilator support:
    • Require a tracheostomy tube.
    • No longer require intensive medical monitoring and services.
  • Patients may choose not to receive home ventilation. Examples of inappropriate candidates for home ventilation include patients who:
    • Have FIo2 requirement > 0.40.
    • Use PEEP > 10 cm H2O.
    • Require continuous invasive monitoring.
    • Lack a mature tracheostomy.
    • Lack able, willing, appropriate caregivers, and/or caregiver respite.
    • Lack adequate financial resources for care in home.
    • Lack adequate physical facilities:
      • Inadequate heat, electricity, sanitation.
      • Presence of fire, health, or safety hazards.
  • For patients on mechanical ventilation in the home a contract and relationship with a home medical equipment company must be developed to provide:
    • Care of ventilator-dependent patient.
    • Provision and maintenance of equipment.
    • Timely provision of disposable supplies.
    • Ongoing monitoring of patient and equipment.
    • Training of patient, caregivers, and clinical staff on proper management of ventilated patient and use and troubleshooting of equipment.
  • Equipment required:
    • Appropriate ventilator with alarms (disconnect and high pressure).
    • Power source.
    • Humidification system.
    • Self-inflating resuscitation bag with tracheostomy adapter.
    • Replacement tracheostomy tubes.
    • Supplemental oxygen, as medically indicated.
    • Communication method for patient.
    • Backup charged battery to run ventilator during power failures.
  • Lay caregiver training and return demonstration must include:
    • Proper setup, use, troubleshooting, maintenance, and cleaning of equipment and supplies.
    • Appropriate patient assessment and management of abnormalities, including response to emergencies, power and equipment failure.
  • Potential complications include:
    • Patient deterioration, need for emergency services.
    • Equipment failure, malfunction.
    • Psychosocial complications, including depression, anxiety, and/or loss of resources (caregiver, financial, detrimental change in family structure or coping capacity).
  • Communication is essential with local fire and utility companies from whom patient would need immediate and additional assistance in event of emergency (eg, power failure, fire).

P.260


P.261


P.262


P.263


P.264


P.265


P.266


P.267


P.268


P.269

THORACIC SURGERIES
Thoracic surgeries (see Table 10-2, page 270) are operative procedures performed to aid in the diagnosis and treatment of certain pulmonary conditions. Procedures include thoracotomy, lobectomy (see Figure 10-6, page 271), pneumonectomy, segmental resection, and wedge resection. These procedures may or may not require chest drainage immediately after surgery.
FIGURE 10-6 Operative procedures. (A) Lobectomy. (B) Pneumonectomy.
Preoperative Management
Goal is to maximize respiratory function to improve the outcome postoperatively and reduce risk of complications
TABLE 10-2 Thoracic Surgery Types
TYPES DESCRIPTION INDICATIONS INDICATIONS
Exploratory thoracotomy Internal view of lung
  • Usually posterolateral parascapular but could be anterior incision
  • Chest tubes after procedure
May be used to confirm carcinoma or for chest trauma (to detect source of bleeding)
Lobectomy Lobe removal
  • Thoracotomy incision at site of lobe removal
  • Chest tubes after procedure
Used when pathology is limited to one area of lung: bronchogenic carcinoma, giant emphysematous blebs or bullae, benign tumors, metastatic malignant tumors, bronchiectasis and fungal infections
Pneumonectomy Removal of an entire lung
  • Posterolateral or anterolateral thoracotomy incision
  • Sometimes there is a rib resection
  • Normally no chest drains or tubes because fluid accumulation in empty space is desirable
Performed chiefly for carcinoma, but may be used for lung abscesses, bronchiectasis, or extensive tuberculosis
Note: Right lung is more vascular than left; may cause more physiologic problems if removed
Segmentectomy (segmental resection) Only certain segment of lung removed
  • Segments function as individual units
Used when pathology is localized (such as in bronchiectasis) and when the patient has preexisting cardiopulmonary compromise
Wedge resection Small localized section of lung tissue removed—usually pie-shaped
  • Incision made without regard to segments
  • Chest tubes after procedure
Performed for random lung biopsy and small peripheral nodules

P.270

  • Encourage the patient to stop smoking to restore bronchial ciliary action and to reduce the amount of sputum and likelihood of postoperative atelectasis.
  • Teach an effective coughing technique.
    • Sit upright with knees flexed and body bending slightly forward (or lie on side with hips and knees flexed if unable to sit up).
    • Splint the incision with hands or folded towel.
    • Take three short breaths, followed by a deep inspiration, inhaling slowly and evenly through the nose.
    • Contract abdominal muscles and cough twice forcefully with mouth open and tongue out.
    • Alternate technique—huffing and coughing—is less painful. Take a deep diaphragmatic breath and exhale forcefully against hand; exhale in a quick distinct pant, or “huff.”
  • Humidify the air to loosen secretions.
  • Administer bronchodilators to reduce bronchospasm.
  • Administer antimicrobials for infection.
  • Encourage deep breathing with the use of incentive spirometer (see Procedure Guidelines 10-25, pages 272 and 273) to prevent atelectasis postoperatively.
  • Teach diaphragmatic breathing (see page 230).
  • Carry out chest physical therapy and postural drainage to reduce pooling of lung secretions.
  • Evaluate cardiovascular status for risk and prevention of complication.
  • Encourage activity to improve exercise tolerance.
  • Administer medications and limit sodium and fluid to improve heart failure, if indicated.
  • Correct anemia, dehydration, and hypoproteinemia with intravenous infusions, tube feedings, and blood transfusions as indicated.
  • Give prophylactic anticoagulant as prescribed to reduce perioperative incidence of deep vein thrombosis and pulmonary embolism.
  • Provide teaching and counseling.
    • Orient the patient to events that will occur in the postoperative period—coughing and deep breathing, suctioning, chest tube and drainage bottles, oxygen therapy, ventilator therapy, pain control, leg exercises and range-of-motion exercises for affected shoulder.
  • Make sure that patient fully understands surgery and is emotionally prepared for it; verify that informed consent has been obtained.
Postoperative Management
  • Use mechanical ventilator until respiratory function and cardiovascular status stabilize. Assist with weaning and extubation.
  • Auscultate chest, monitor vital signs, monitor ECG, and assess respiratory rate and depth frequently. Arterial line, CVP, and pulmonary artery catheter are usually used.
  • Monitor ABG values and/or Sao2 frequently.
  • Monitor and manage chest drainage system to drain fluid, blood, clots, and air from the pleura after surgery (see page 274). Chest drainage is usually not used after pneumonectomy, however, because it is desirable that the pleural space fills with an effusion, which eventually obliterates the space.

P.271

Complications
  • Hypoxia—watch for restlessness, tachycardia, tachypnea, and elevated blood pressure.
  • Postoperative bleeding—monitor for restlessness, anxiety, pallor, tachycardia, and hypotension.
  • Pneumonia; atelectasis—monitor for fever, chest pain, dyspnea.
  • Bronchopleural fistula from disruption of a bronchial suture or staple; bronchial stump leak.
    • Observe for sudden onset of respiratory distress or cough productive of serosanguineous fluid.
    • Position with the operative side down.
    • Prepare for immediate chest tube insertion and/or surgical intervention.
  • Cardiac dysrhythmias (usually occurring third to fourth postoperative day); myocardial infarction or heart failure.
Nursing Diagnoses
  • Ineffective Breathing Pattern related to wound closures
  • Risk for Deficient Fluid Volume related to chest drainage and blood loss
  • Acute Pain related to wound closure and presence of drainage tubes in the chest
  • Impaired Physical Mobility of affected shoulder and arm related to wound closure and the presence of drainage tubes in the chest.
Nursing Interventions
Maintaining Adequate Breathing Pattern
  • Auscultate chest for adequacy of air movement to detect bronchospasm, consolidation.
  • Obtain ABG analysis and pulmonary function measurements as ordered.
  • Monitor level of consciousness and inspiratory effort closely to begin weaning from ventilator as soon as possible.
  • Suction frequently using meticulous aseptic technique.
  • Elevate the head of the bed 30 to 40 degrees when patient is oriented and blood pressure is stabilized to improve movement of diaphragm.
  • Encourage coughing and deep-breathing exercises and use of an incentive spirometer to prevent bronchospasm, retained secretions, atelectasis, and pneumonia.
Stabilizing Hemodynamic Status
  • Take blood pressure, pulse, and respiration every 15 minutes or more frequently as indicated; extend the time intervals according to the patient's clinical status.
  • Monitor heart rate and rhythm by way of auscultation and ECG, because dysrhythmias are frequently seen after thoracic surgery.
  • Monitor the central venous pressure for prompt recognition of hypovolemia and for effectiveness of fluid replacement.
  • Monitor cardiac output and pulmonary artery systolic, diastolic, and wedge pressures. Watch for subtle changes, especially in the patient with underlying cardiovascular disease.
  • Assess chest tube drainage for amount and character of fluid.
    • Chest drainage should progressively decrease after first 12 hours.
    • Prepare for blood replacement and possible reoperation to achieve hemostasis if bleeding persists.
  • Maintain intake and output record, including chest tube drainage.
    P.272

    P.273

  • Monitor infusions of blood and parenteral fluids closely because patient is at risk for fluid overload if portion of pulmonary vascular system has been reduced.
Achieving Adequate Pain Control
  • Provide appropriate pain relief—pain limits chest excursions, thereby decreasing ventilation. Severity of pain varies with type of incision and with the patient's reaction to and ability to cope with pain. Usually a posterolateral incision is the most painful.
  • Give opioids (usually by continuous I.V. infusion or by epidural catheter by way of patient-controlled analgesia (PCA) pump) for pain relief, as prescribed, to permit patient to breathe more deeply and cough more effectively. Avoid respiratory and CNS depression with too much opioid; patient should be alert enough to cough.
  • Assist with intercostal nerve block or cryoanalgesia (intercostal nerve freezing) for pain control as ordered (see page 301).
  • Position for comfort and optimal ventilation (head of bed elevated 15 to 30 degrees); this also helps residual air to rise in upper portion of pleural space, where it can be removed by the chest tube.
    • Patients with limited respiratory reserve may not be able to turn on unoperated side, because this may limit ventilation of the operated side.
    • Vary the position from horizontal to semierect to prevent retention of secretions in the dependent portion of the lungs.
  • Encourage splinting of incision with pillow, folded towel, or hands, while turning.
  • Teach relaxation techniques such as progressive muscle relaxation and imagery to help reduce pain.
Increasing Mobility of Affected Shoulder
  • Begin range-of-motion exercise of arm and shoulder on affected side immediately to prevent ankylosis of the shoulder (“frozen” shoulder).
  • Perform exercises at time of maximal pain relief.
  • Encourage patient to actively perform exercises three to four times a day, taking care not to disrupt chest tube or I.V. lines.

P.274

Patient Education and Health Maintenance
  • Advise that there will be some intercostal pain for several weeks, which can be relieved by local heat and oral analgesia.
  • Advise that weakness and fatigability are common during the first 3 weeks after a thoracotomy, but exercise tolerance will improve with conditioning.
  • Suggest alternating walking and other activities with frequent short rest periods. Walk at a moderate pace and gradually extend walking time and distance.
  • Encourage continuing deep-breathing exercises for several weeks after surgery to attain full expansion of residual lung tissue.
  • Instruct on maintaining good body alignment to ensure full lung expansion.
  • Advise that chest muscles may be weaker than normal for 3 to 6 months after surgery, so patient must avoid lifting more than 20 lb (9 kg) until complete healing has taken place.
  • Warn that any activity that causes undue fatigue, increased shortness of breath, or chest pain should be stopped immediately.
  • Because all or part of one lung has been removed, warn to avoid respiratory irritants (smoke, fumes, high level of air pollution).
    • Avoid anything that may cause spasms of coughing.
    • Sit in nonsmoking areas in public places.
  • Encourage patient to have an annual influenza injection and obtain a pneumococcal pneumonia vaccine.
  • Encourage patient to keep follow-up visits.
  • Instruct patient to prevent respiratory infections by frequent handwashing and avoiding others with respiratory infections.
Evaluation: Expected Outcomes
  • Respirations 18 to 24, adequate depth; lungs clear; ABG values and Sao2 within normal limits
  • Blood pressure, CVP, and pulse stable
  • Coughs and turns independently; reports relief of pain
  • Performs active range of motion of affected arm and shoulder
CHEST DRAINAGE
Chest drainage is the insertion of a tube into the pleural space to evacuate air or fluid, or to help regain negative pressure. Whenever the chest is opened, from any cause, there is loss of negative pressure, which can result in collapse of the lung. The collection of air, fluid, or other substances in the chest can compromise cardiopulmonary function and even cause collapse of the lung, because these substances take up space.
It is necessary to keep the pleural space evacuated postoperatively and to maintain negative pressure within this potential space. Therefore, during or immediately after thoracic surgery, chest tubes/catheters are positioned strategically in the pleural space, sutured to the skin, and connected to some type of drainage apparatus to remove the residual air and drainage fluid from the pleural or mediastinal space. This assists in the reexpansion of remaining lung tissue.
Chest drainage can also be used to treat spontaneous pneumothorax, or hemothorax/pneumothorax caused by trauma. Sites for chest tube placement are:
  • For pneumothorax (air)—second or third interspace along midclavicular or anterior axillary line.
  • For hemothorax (fluid)—sixth or seventh lateral interspace in the midaxillary line.
Principles of Chest Drainage
  • Many types of commercial chest drainage systems are in use, most of which use the water-seal principle. The chest tube/catheter is attached to a bottle, using a one-way valve principle. Water acts as a seal and permits air and fluid to drain from the chest. However, air cannot reenter the submerged tip of the tube.
  • Chest drainage can be categorized into three types of mechanical systems (see Figure 10-7).
    FIGURE 10-7 Chest drainage systems. (A) Strategic placement of a chest catheter in the pleural space. (B) Three types of mechanical drainage systems. (C) A Pleur-Evac operating system: (1) the collection chamber, (2) the water seal chamber, and (3) the suction control chamber. The Pleur-Evac is a single unit with all three bottles identified as chambers.
Single-Bottle Water-Seal System
  • The end of the drainage tube from the patient's chest is covered by a layer of water, which permits drainage of air and fluid from the pleural space, but does not allow air to move back into the chest. Functionally, drainage depends on gravity, on the mechanics of respiration, and, if desired, on suction by the addition of controlled vacuum.
  • The tube from the patient extends approximately 1 inch (2.5 cm) below the level of the water in the container. There is a vent for the escape of any air that may be leaking from the lung. The water level fluctuates as the patient breathes; it goes up when the patient inhales and down when the patient exhales.
  • At the end of the drainage tube, bubbling may or may not be visible. Bubbling can mean either persistent leakage of air from the lung or other tissues or a leak in the system.
Two-Bottle Water-Seal System
  • The two-bottle system consists of the same water-seal chamber, plus a fluid-collection bottle.
  • Drainage is similar to that of a single unit, except that when pleural fluid drains, the underwater-seal system is not affected by the volume of the drainage.
  • Effective drainage depends on gravity or on the amount of suction added to the system. When vacuum (suction) is added to the system from a vacuum source, such as wall suction, the connection is made at the vent stem of the underwater-seal bottle.
  • The amount of suction applied to the system is regulated by the wall gauge.
Three-Bottle Water-Seal System
  • The three-bottle system is similar in all respects to the two-bottle system, except for the addition of a third bottle to control the amount of suction applied.
    P.275

  • The amount of suction is determined by the depth to which the tip of the venting glass tube is submerged in the water.
  • In the three-bottle system (as in the other two systems), drainage depends on gravity or the amount of suction applied. The amount of suction in the three-bottle system is controlled by the manometer bottle. The mechanical suction motor or wall suction creates and maintains a negative pressure throughout the entire closed drainage system.
  • The manometer bottle regulates the amount of vacuum in the system. This bottle contains three tubes:
    • A short tube above the water level comes from the water-seal bottle.
    • Another short tube leads to the vacuum or suction motor, or to wall suction.
    • The third tube is a long tube that extends below the water level in the bottle and opens to the atmosphere outside the bottle. This tube regulates the amount of vacuum in the system, depending on the depth to which the tube is submerged—the usual depth is 7½ inches (20 cm).
  • When the vacuum in the system becomes greater than the depth to which the tube is submerged, outside air is sucked into the system. This results in constant bubbling in the manometer bottle, which indicates that the system is functioning properly.
  • In the commercially available systems, the three bottles are contained in one unit and identified as “chambers” (see Figure 10-7C). The principles remain the same for the commercially available products as they do for the glass bottle system.
Nursing and Patient Care Considerations
  • Assist with chest tube insertion (see Procedure Guidelines 10-26, pages 276 and 277).
  • Assess patient's pain at insertion site and give medication appropriately. If patient is in pain, chest excursion and lung inflation will be hampered.
  • Maintain chest tubes to provide drainage and enhance lung reinflation (see Procedure Guidelines 10-27, pages 278 and 279).

P.276

No comments:

Blog Archive